The myelodysplastic syndromes pose important clinical and scientific challenges which in recent years have attracted growing interest within haemato-oncology and molecular genetics. Their potential as a model for the study of human leukaemogenesis makes this one of the most exciting fields in contem
Myelodysplastic Syndromes
β Scribed by H. Joachim Deeg, David T. Bowen, Steven D. Gore, Torsten Haferlach, Michelle M. Le Beau, Charlotte Niemeyer (auth.)
- Publisher
- Springer-Verlag Berlin Heidelberg
- Year
- 2013
- Tongue
- English
- Leaves
- 245
- Series
- Hematologic Malignancies
- Edition
- 2
- Category
- Library
No coin nor oath required. For personal study only.
β¦ Synopsis
The diagnosis of myelodysplastic syndromes (MDS), a heterogeneous group of clonal hematopoietic disorders, is being made with increasing frequency over the past decade owing to increased recognition, improved understanding, and an aging population. This book, completely updated since the first edition, summarizes in a concise and focused way the current knowledge of all aspects of MDS. Clinical presentation, etiology, epidemiology, molecular biology, classification, and staging are all discussed. Clear guidance is provided on diagnosis and differential diagnosis, and treatment strategies are explained in detail, including administration of hematopoietic growth factors, biologically based treatment, hematopoietic stem cell transplantation, and supportive care. Additional chapter is devoted to MDS in children. This practically oriented book will be of value to a broad spectrum of students and practitioners in the field.
β¦ Table of Contents
Front Matter....Pages i-viii
Front Matter....Pages 1-1
Clinical Presentation and Differential Diagnosis....Pages 3-8
Epidemiology and Etiology....Pages 9-38
Front Matter....Pages 39-39
Cytogenetic Diagnosis of Myelodysplastic Syndromes....Pages 41-72
MDS Stem Cell Biology....Pages 73-84
The Biology of Myelodysplastic Syndrome Associated with Isolated del(5q)....Pages 85-95
A Personalized Molecular Pathogenesis of MDS....Pages 97-109
Myelodysplastic/Myeloproliferative Neoplasms....Pages 111-126
Classification and Staging of Myelodysplastic Syndromes....Pages 127-139
Immunophenotyping in Myelodysplastic Syndromes....Pages 141-152
Prognostic Models for Patients with Myelodysplastic Syndromes....Pages 153-167
Front Matter....Pages 169-169
Management of Low-Risk MDS....Pages 171-187
Management of High-Risk Myelodysplastic Syndrome....Pages 189-210
Hematopoietic Cell Transplantation (HCT)....Pages 211-228
Front Matter....Pages 229-229
Myelodysplastic Syndrome in Children....Pages 231-240
Back Matter....Pages 241-245
β¦ Subjects
Hematology; Internal Medicine; Oncology; Pathology; Transplant Surgery
π SIMILAR VOLUMES
<p><p>This book reviews the standard diagnostic and therapeutic management of patients with myelodysplastic syndromes (MDS) and examines ongoing research developments in the field. The importance of appropriate prognostic stratification, taking into account recent advances in understanding of the mo
<p><p>Myelodysplastic syndromes (MDS) are the most common hematological malignancies involving mostly the elderly population. The major morbidity relates to patientsβ symptomatic cytopenias.MDS was previously named as βpreleukemia β or β smoldering leukemiaβ as the lack of terminal cells in MDS and
This book summarizes our current knowledge of MDS, from very basic aspects to the clinical management. It provides guidance to the diagnosis, an understanding of disease mechanisms, and a discussion of treatment strategies.
<P>This book summarizes our current knowledge of MDS, from very basic aspects to the clinical management. It provides guidance to the diagnosis, an understanding of disease mechanisms, and a discussion of treatment strategies.</P>
<p><span>This book summarizes our current knowledge of MDS, from very basic aspects to the clinical management. It provides guidance to the diagnosis, an understanding of disease mechanisms, and a discussion of treatment strategies.</span></p>